There's a new player on the antibody-drug conjugate (ADC) scene. UK-based Pheon Therapeutics has entered stage right with $68 million in funding that will be used to fund development of a pipeline of ...

The defection of the 2023 Labour Party presidential candidate, Peter Obi, to the African Democratic Congress has begun to boost the party’s political strength in the South, with no fewer than eight ...

Antibody-drug conjugates are receiving unrivaled attention across the biopharma sector. Fueled by Enhertu’s tumor-agnostic accelerated approval, practice changing combination results from Seagen and ...

The All Progressives Congress has reaffirmed its commitment to President Bola Tinubu’s 2027 re-election bid, assuring that victory is certain, even as former presidential candidate Peter Obi dumped ...

ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors. Its flagship product ...

VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 3.47M Sep 30, 2025 3.02% 252,524,543 VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund 2.62M Sep 30, 2025 2.28% 190,907,395 COHEN & STEERS ...

Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.

The League of Legends ADC role is the damage engine of every team composition. With games often decided around two or three item spikes, strong bot lanes ultimately dictate how early skirmishes play ...

The FDA initially placed the Phase III IDeate-Lung02 study on hold due to a “higher than expected” number of deaths in patients treated with ifinatamab deruxtecan. The FDA has lifted its partial ...